Athraquinones a
CAS 72-48-0
Athraquinones a (CAS 72-48-0) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 35558.08208955224 nM | 53 | - |
| - | GI50 | 46896.04076923077 nM | 52 | - |
| - | IC50 | 56434.5048 nM | 24 | - |
| - | AC50 | 18349.7 nM | 4 | - |
| - | Ki | 1090 nM | 3 | - |
| - | EC50 | 60200 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Athraquinones a used for in pharmaceutical contexts?
Athraquinones a (CAS 72-48-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Athraquinones a?
No adverse-event association or SIDER side-effect rows are rendered for Athraquinones a in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Athraquinones a also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for CI 58000 with EU status "restricted".
What clinical phase is Athraquinones a in?
No phase 1-4 clinical development badge is rendered for Athraquinones a because the matched compound identifier rows do not contain a max-phase value.